August 31, 2022
Center for Regenerative Biotherapeutics announces cell and gene therapy accelerator
Mayo Clinic, Hibiscus BioVentures (Hibiscus) and Innoforce announce the launch of Mayflower BioVentures, a cell and gene therapy accelerator dedicated to identifying and forming companies around technologies that address unmet patient needs. This academic and industry relationship will establish independent cell and gene therapy companies to advance the development of Mayo Clinic technologies through preclinical […]
Tags: #Business accelerator, #cell therapies, #gene therapie, #Hibiscus BioVentures, #Innoforce, #Mayo Clinic Center for Regenerative Biotherapeutics